Lisa Michelle Kallebo serves as Executive at ADC Therapeutics SA, where they oversee executive responsibilities. Since joining the company, Lisa Michelle Kallebo has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 6, 2025 involved selling 7,140 shares valued at $23.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 6, 2025 | ADCT | $23.5K | Payment | 7,140 | $3.29 | Discretionary |
Lisa Michelle Kallebo currently holds 70,757 shares of ADC Therapeutics SA (ADCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lisa Michelle Kallebo has been a net neutral trader of ADCT stock. They have purchased $0 and sold $0 worth of shares.
Lisa Michelle Kallebo's most recent insider trade was on Dec 6, 2025, when they sold 7,140 shares at $3.29 per share.
Get notified when new Form 4 filings are submitted